who is who in Syn Bio
Get flash to fully experience Pearltrees
Craig Venter
John Craig Venter (born October 14, 1946) is an American biologist and entrepreneur , most famous for his role in being one of the first to sequence the human genome [ 1 ] and for his role in creating the first cell with a synthetic genome in 2010. [ 2 ] [ 3 ] Venter founded Celera Genomics , The Institute for Genomic Research and the J. Craig Venter Institute , now working at the latter to create synthetic biological organisms and to document genetic diversity in the world's oceans. He was listed on Time magazine's 2007 and 2008 Time 100 list of the most influential people in the world. In 2010, the British magazine New Statesman listed Craig Venter at 14th in the list of "The World's 50 Most Influential Figures 2010". [ 4 ] [ edit ] Family and education Venter was born in Salt Lake City , Utah .
Hamilton O. Smith
Hamilton O. Smith received an A.B. degree in mathematics at the University of California, Berkeley in 1952 and the M.D. degree from Johns Hopkins University in 1956. After six years of clinical work in medicine (1956-1962), he carried out research on Salmonella phage P22 lysogeny at the University of Michigan, Ann Arbor (1962-1967).Drew Endy (born 1970) is a synthetic biologist. He was a junior fellow for 3 years and later an assistant professor in the Department of Biological Engineering at MIT . In September 2008, he moved to Palo Alto to become an assistant professor in the Department of Bioengineering at Stanford University . Silicon Valley's concentration of computer scientists and engineers, in addition to Stanford's broad focus on engineering as well as ethics and the humanities, are believed to be the main reason for his move according to press reports. [ 1 ] His wife Christina Smolke moved from the California Institute of Technology to Stanford in January 2009.
Drew Endy
Stanislas Leibler
Even the simplest of organisms, such as bacteria, are capable of processing information in a highly sophisticated manner, adapting to varying environments and evolving new functions. Dr. Leibler is interested in the quantitative description of microbial systems, both on cellular and population levels. In recent years, the field of molecular biology has moved away from the study of individual components and toward the study of how they interact, creating a “systemic” approach that seeks an appropriate and quantitative description of cells and organisms. Dr. Leibler’s laboratory is developing both the theoretical and experimental methods necessary for conducting studies on the collective behavior of biomolecules, cells and organisms.
Martin Fussenegger is professor of biotechnology and bioengineering at the Department of Biosystems Science and Engineering in Basel (D-BSSE) of the Swiss Federal Institute of Technology, the ETH Zurich. In 1992 he graduated in molecular biology and genetics with Werner Arber at the Biocenter in Basel, joined the Max Planck Institute of Biology for his Ph.D. thesis in medical microbiology (1993-1994) and continued his studies on host-pathogen interactions at the Max Planck Institute of Infection Biology as a postdoctoral fellow (1995). In 1996, Martin Fussenegger joined the research unit of James E. Bailey at the ETH Institute of Biotechnology as an independent group leader where he refocused his research on mammalian cell engineering, a topic for which he received his habilitation in 2000.
Martin Fussenegger
Jay Keasling
The page you are looking for no longer exists. Perhaps you can return back to the site's homepage and see if you can find what you are looking for. Or, you can try finding it with the information below.Professor Emeritus, Biomedical Engineering Dr. Cantor is currently on leave of absence, acting as Chief Scientific Officer at Sequenom , Inc. in San Diego, California.
Charles Cantor
Michael B. Elowitz
Like the flickering green bacteria in one of his best known experiments, Michael Elowitz is a leading light in the field of synthetic biology. In 2000, Elowitz broke open the fledgling science, which is concerned with understanding and building genetic circuits, by programming E. coli bacteria to blink like Christmas lights. The bacteria glow green after three genes in a looped sequence repress the next, one by one, and then spark a gene that turns on a fluorescent protein. After the circuit runs its course, the bacteria stop making the fluorescent protein and turn off until the cycle repeats. "It's like a game of rock-paper-scissors," says Elowitz, who did the work with his adviser Stanislas Leibler. "You have three genes, and each one represses the next one."James Collins (Boston University) - Wikipedia, the free encyclopedia
James J. Collins (June 26, 1965) is an American bioengineer , Professor of Biomedical Engineering at Boston University , and a Howard Hughes Medical Institute (HHMI) Investigator. He is one of the founders of the emerging field of synthetic biology , and a pioneering researcher in systems biology , having made fundamental discoveries regarding the actions of antibiotics and the emergence of resistance. [ 2 ]